ESG

A looming 10-million-ton copper deficit threatens to derail the AI revolution and the green energy transition, sparking a new era of geopolitical competition.

Replicate Bioscience secures major funding to develop next-gen self-replicating RNA vaccines, aiming for more durable and accessible global health solutions.

Luxury brand owner Tapestry partners with Pivot Energy on Illinois solar projects, powering homes and funding new green job training programs for locals.

Westwater Resources heads to a key investor conference, carrying the weight of its Alabama graphite projects and the future of America's EV supply chain.

How a blend of private capital and pragmatic regulation is turning Singapore into a global hub for longevity research, pushing scientific and ethical boundaries.

The software giant is launching AI-powered AP automation, mobile payments, and integrated financing to tackle contractor cash flow and operational headaches.

As the eVTOL race intensifies, Vertical Aerospace appoints key execs from Lotus, Nike, and AB InBev to spearhead its push for certification and scale.

The UK charity is launching The Waqf Fund, blending ancient Islamic finance with modern investment to create a self-sustaining model for global aid.

A $10 billion fund. Two competing visions. Wingspan Advisors' unique 'Alpha Summit' will decide the future of its ambitious new investment vehicle.

Pharma giant Bayer partners with biotech innovator Soufflé to develop a groundbreaking siRNA therapy, aiming to deliver genetic medicine directly to the heart.

A new clinical benchmark published in a Nature journal reveals a Chinese AI is the safest and most effective, challenging Silicon Valley's dominance.

At CES 2026, BLUETTI moves beyond portable power, unveiling smart home batteries, a sodium-ion first, and a vision for a decentralized energy grid.

Azafaros presents its promising drug, nizubaglustat, for untreatable rare neurological disorders, backed by major funding and late-stage clinical trials.

Biotech leader Arrowhead Pharmaceuticals prices upsized offerings, signaling strong investor confidence and fueling its next wave of RNAi therapies.

The pharmaceutical giant is expanding its partnership with Veeva, adopting a next-gen CRM with agentic AI to transform its global commercial execution.

South Korean gim specialist Daingt is leveraging proprietary data and a 20-year legacy to innovate its seaweed, aiming to dominate the booming global market.

New US dietary guidelines champion protein, full-fat dairy, and kefir, signaling a major shift in nutrition policy and a boon for the functional food market.

CMS withdraws a controversial rule, ensuring patient access to advanced wound care, but a new payment model still looms over the MedTech industry.

A century-old Wisconsin fabricator has won a top industry award by blending Cybertruck-level tech with a radical focus on employee enrichment.

Amid industry headwinds, Trinity Health invests $2.9B in community health, pioneering a 'care dividend' to tackle housing, food, and access to care.